Nasdaq · Healthcare
DELCATH SYSTEMS, INC. (DCTH)
As-reported financials and recent SEC filings for DELCATH SYSTEMS, INC., latest fiscal period FY2025. Every figure is pulled straight from the company’s EDGAR filings — no estimates.
Snapshot
Revenue
$85.2M
Net income
$2.7M
Net margin
3.2%
Diluted EPS
$0.07
ROE
2.4%
P/E (TTM)
—
Market cap
—
Debt / equity
—
Income statement (as reported)
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $85.2M | $37.2M | $2.1M | $2.7M | $3.6M |
| Gross profit | $73.4M | $31.0M | $1.4M | $2.0M | $2.9M |
| Operating income | $660,000 | $-12.4M | $-38.2M | $-33.9M | $-24.5M |
| Net income | $2.7M | $-26.4M | $-47.7M | $-36.5M | $-25.6M |
| Diluted EPS | $0.07 | $-0.93 | $-2.94 | $-4.12 | $-3.59 |
Source: company XBRL financial statements on SEC EDGAR.
Recent SEC filings
42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →42026-05-14
View on EDGAR →8-K2026-05-14
View on EDGAR →10-Q2026-05-07
View on EDGAR →8-K2026-05-07
View on EDGAR →Largest Healthcare peers
Go deeper on DCTH
Search DELCATH SYSTEMS, INC.’s filings with cited answers, compare it against peers, build an operating model, and track it in your portfolio — all in one place.
Start freeOr check your whole portfolio free — no account needed.
Data sourced from SEC EDGAR (public domain). Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only — not investment advice.